← All organizations
wuhan optics
For profit
Also known as: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. | Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Hubei, China | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China
Highest phase reached
Phase 2
First clinical trial
Jul 20, 2021Last known activity
Jan 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 6 trials)
Phase 2 (4 own, 0 via acquisition)
Recent trials (7)
- NCT06677255Lead sponsorPhase 1/Phase 2Jan 31, 2025
- NCT06230822Lead sponsorPhase 1Feb 29, 2024
- NCT05984303CollaboratorPhase 1Aug 30, 2023
- NCT05507697CollaboratorPhase 1/Phase 2May 19, 2022
- NCT05507697CollaboratorPhase 1/Phase 2May 19, 2022
- NCT05173441Lead sponsorPhase 2Dec 30, 2021
- NCT05507762CollaboratorPhase 1/Phase 2Jul 20, 2021
Details
- Last known activity
- Jan 31, 2025